Brian W Metcalf

This inventor holds 19 USPTO granted patents and 2 published patent applications, plus 5 CIPO patents, primarily in Steroid Inhibitors. Top assignees: Smithkline Beecham Corporation, Smithkline Beckman Corporation, Other. Active years: 1989-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brian W Metcalf. Retrieved from https://idiyas.com/inventor/brian-w-metcalf-vujxvujb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 2)

% Patents Active = 100.0

CIPO Patents = 5 (Patent Applications = 6)

Average Co-Inventor Count = 3.3

ph-index = 9

Forward Citations = 251(Granted Patents)

Location History:

Philadelphia, PA (US) (1992)
Radnor, PA (US) (1989 - 2000)

Company Filing History:

14 out of 2,198

Smithkline Beecham Corporation

patents

4 out of 207

Smithkline Beckman Corporation

patents

1 out of 834,570

Other

patents

Years Active: 1989-2000

Loading Chart...

Areas of Expertise:

Platelet Aggregation

Steroid Inhibitors

5-Alpha-Reductase

Cytokine Inhibitors

Hydroxamic Acid

Steroidal Derivatives

Phosphinic Acid

Aromatic Steroids

Nitro-Steroid Derivatives

Carboxy-Alkyl Derivatives

HMG-COA Regulator

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6028087 - Platelet aggregation inhibiting compounds (2000-02-22),

2. 5726192 - Platelet aggregation inhibiting compounds (1998-03-10),

3. 5665753 - Cytokine inhibiting imidazole substituted hydroxamic acid derivatives (1997-09-09),

4. 5237065 - Steroid 5-alpha-reductase inhibitors (1993-08-17),

5. 5137882 - Steroidal 3-acetic acid derivatives as 5-alpha-reductase inhibitors (1992-08-11),

6. 5110939 - Intermediates in the preparation of steriod 5-alpha-reductase inhibitors (1992-05-05),

7. 5041433 - 11-keto or hydroxy 3,5-diene steroids as inhibitors of steriod (1991-08-20),

8. 5032586 - 7-keto or hydroxy 3,5-diene steroids as inhibitors of steroid 5-alpha (1991-07-16),

9. 5026882 - Phosphinic acid substituted steroids as inhibitors of steroid (1991-06-25),

10. 5023250 - Steroidal 14.alpha.-carboxy-alkyl derivatives as regulators of HMG-COA (1991-06-11),

11. 5017568 - Steriod 5-alpha-reductase inhibitors (1991-05-21),

12. 4970205 - Sulfonic acid substituted aromatic steroids as inhibitors of steroid (1990-11-13),

13. 4970204 - 3-substituted nitro-steroid derivatives as 5-.alpha.-reductase inhibitors (1990-11-13),

14. 4954446 - Aromatic steroid 5-.alpha.-reductase inhibitors (1990-09-04),

15. 4946834 - Phosphonic acid substituted steroids as steroid 5.alpha.-reductase (1990-08-07),

Title: Brian W. Metcalf: Innovator in Platelet Aggregation Inhibiting Compounds

Introduction: Brian W. Metcalf, based in Radnor, PA, is a prolific inventor known for his significant contributions to the field of medical innovations, particularly in platelet aggregation inhibitors. With a total of 19 patents to his name, he has made remarkable strides in developing compounds that hold potential in therapeutic applications.

Latest Patents: Among his latest breakthroughs are advanced platelet aggregation inhibiting compounds, specifically those characterized by unique formulas. These innovations aim to improve treatments for various medical conditions linked to platelet aggregation, showcasing his commitment to enhancing healthcare through scientific advancements.

Career Highlights: Brian W. Metcalf's career has been marked by tenure at prestigious organizations, including SmithKline Beecham Corporation and SmithKline Beckman Corporation. His work at these companies has allowed him to merge research with practical applications, ultimately leading to the successful development of several patentable inventions.

Collaborations: Throughout his career, Metcalf has collaborated with notable scientists such as Dennis Alan Holt and Mark A. Levy. These partnerships have fostered an environment of innovation, enabling the exchange of ideas and expertise that have propelled his research forward.

Conclusion: Brian W. Metcalf remains a key figure in the realm of medical research and innovation. His dedication to exploring new compounds and therapies continues to inspire advancements in the field, leaving an indelible mark on the world of inventions related to health.

Profile summary based on public USPTO records.